MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CVSI had -$176K decrease in cash & cash equivalents over the period. -$516K in free cash flow.

Cash Flow Overview

Change in Cash
-$176K
Free Cash flow
-$516K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from note payable
    • Inventory
    • Benefit from reversal of accrued...
    • Others
Negative Cash Flow Breakdown
    • Cost of goods sold
    • General and administrative expen...
    • Sales expense
    • Others

Cash Flow
2025-12-31
Product sales, net
13,789
Cost of goods sold
7,037
Gross profit
6,752
Research and development expense
122
Sales expense
2,803
Marketing expense
1,666
General and administrative expense
3,153
Benefit from reversal of accrued payroll taxes
-522
Total operating expenses
7,222
Operating loss
-470
Other expense, net
-479
Loss before income taxes
-949
Income tax expense (benefit)
9
Net loss
-958
Depreciation and amortization
192
Stock-based compensation
497
Amortization of debt discount
513
Amortization of right of use assets
238
Gain in fair value of contingent consideration liabilities
0
Gain on debt extinguishment
38
Benefit from reversal of accrued payroll tax (note 12)
-522
Deferred taxes
-3
Other
138
Accounts receivable, net
-124
Inventory
-827
Prepaid expenses and other
-166
Accounts payable and accrued expenses
-1,342
Operating lease liability
-245
Net cash flows used in operating activities
-407
Purchases of property and equipment
109
Acquisition of business, net of cash acquired
0
Net cash flows used in investing activities
-109
Proceeds from note payable
1,650
Debt issuance costs related to note payable
90
Repayment of note payable
1,050
Repayment of unsecured debt
173
Net cash flows provided by financing activities
337
Effect of exchange rate changes on cash
3
Net decrease in cash
-176
Cash, beginning of year
454
Cash, end of year
278
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from notepayable$1,650K Net cash flowsprovided by financing...$337K Effect of exchange ratechanges on cash$3K Canceled cashflow$1,313K Net decrease in cash-$176K Canceled cashflow$340K Inventory-$827K Amortization of debt discount$513K Stock-based compensation$497K Amortization of right of useassets$238K Depreciation andamortization$192K Prepaid expenses andother-$166K Other$138K Accounts receivable, net-$124K Deferred taxes-$3K Repayment of note payable$1,050K Repayment of unsecureddebt$173K Debt issuance costsrelated to note payable$90K Net cash flows usedin operating...-$407K Canceled cashflow$2,698K Net cash flows usedin investing...-$109K Accounts payable andaccrued expenses-$1,342K Net loss-$958K Benefit from reversal ofaccrued payroll tax...-$522K Operating lease liability-$245K Gain on debtextinguishment$38K Purchases of property andequipment$109K Product sales, net$13,789K Loss before incometaxes-$949K Income tax expense(benefit)$9K Gross profit$6,752K Canceled cashflow$7,037K Other expense, net-$479K Operating loss-$470K Canceled cashflow$6,752K Benefit from reversal ofaccrued payroll taxes-$522K Cost of goods sold$7,037K Total operatingexpenses$7,222K Canceled cashflow$522K General andadministrative expense$3,153K Sales expense$2,803K Marketing expense$1,666K Research and developmentexpense$122K

CV Sciences, Inc. (CVSI)

CV Sciences, Inc. (CVSI)